ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $202.76 +2.11%
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
DBVT, FNGR, SFNC, More
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
DBVT, FNGR, SFNC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- Netflix (NFLX) Tops Q2 EPS by 1c, Offers Guidance
- FingerMotion, Inc. (FNGR) Reports Q1 Loss of $0.03
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
